Department of Nuclear Medicine, Hospital Universitari Son Espases, 07010 Palma, Spain; Department of Medicine, University of the Balearic Islands, E-07122 Palma, Spain; Health Research Institute of the Balearic Islands (IdISBa), 07010 Palma, Spain.
Health Research Institute of the Balearic Islands (IdISBa), 07010 Palma, Spain; SCOPIA Research Group, University of the Balearic Islands, E-07122 Palma, Spain.
Neuroimage Clin. 2024;42:103616. doi: 10.1016/j.nicl.2024.103616. Epub 2024 May 6.
The main objective was to characterize the tracer uptake kinetics of [F]fluoromethylcholine ([F]F-CHO) in high-grade gliomas (HGG) through a full PET kinetic modeling approach. Secondarily, we aimed to explore the relationship between the PET uptake measures and the HGG molecular features.
Twenty-four patients with a suspected diagnosis of HGG were prospectively included. They underwent a dynamic brain [F]F-CHO-PET/CT, from which a tumoral time-activity curve was extracted. The plasma input function was obtained through arterial blood sampling with metabolite correction. These data were fitted to 1- and 2-tissue-compartment models, the best of which was selected through the Akaike information criterion. We assessed the correlation between the kinetic parameters and the conventional static PET metrics (SUV, SUV and tumor-to-background ratio TBR). We explored the association between the [F]F-CHO-PET quantitative parameters and relevant molecular biomarkers in HGG.
Tumoral time-activity curves in all patients showed a rapid rise of [F]F-CHO uptake followed by a plateau-like shape. Best fits were obtained with near-irreversible 2-tissue-compartment models. The perfusion-transport constant K and the net influx rate K showed strong correlation with SUV (r = 0.808-0.861), SUV (r = 0.794-0.851) and TBR (r = 0.643-0.784), p < 0.002. HGG was confirmed in 21 patients, of which those with methylation of the O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter showed higher mean K (p = 0.020), K (p = 0.025) and TBR (p = 0.001) than the unmethylated ones.
[F]F-CHO uptake kinetics in HGG is best explained by a 2-tissue-compartment model. The conventional static [F]F-CHO-PET measures have been validated against the perfusion-transport constant (K) and the net influx rate (K) derived from kinetic modeling. A relationship between [F]F-CHO uptake rate and MGMT methylation is suggested but needs further confirmation.
本研究旨在通过全 PET 动力学建模方法,对高级别胶质瘤(HGG)中 [F]氟甲基胆碱([F]F-CHO)的示踪剂摄取动力学进行特征描述。其次,我们旨在探索 PET 摄取指标与 HGG 分子特征之间的关系。
24 名疑似 HGG 的患者被前瞻性纳入研究。他们接受了动态脑 [F]F-CHO-PET/CT 检查,从该检查中提取出肿瘤时间-活性曲线。通过动脉采血并进行代谢物校正获得血浆输入函数。这些数据通过 1 组织室和 2 组织室模型进行拟合,通过赤池信息量准则(Akaike information criterion)选择最佳模型。我们评估了动力学参数与传统静态 PET 指标(SUV、SUV 和肿瘤-背景比 TBR)之间的相关性。我们探讨了 [F]F-CHO-PET 定量参数与 HGG 中相关分子生物标志物之间的关联。
所有患者的肿瘤时间-活性曲线均显示出 [F]F-CHO 摄取的快速上升,随后呈平台样形状。使用近乎不可逆的 2 组织室模型获得最佳拟合。灌注-转运常数 K 和净流入率 K 与 SUV(r=0.808-0.861)、SUV(r=0.794-0.851)和 TBR(r=0.643-0.784)具有强相关性,p<0.002。21 名患者的 HGG 得到了证实,其中甲基化 O-6-甲基鸟嘌呤-DNA 甲基转移酶(MGMT)基因启动子的患者的平均 K(p=0.020)、K(p=0.025)和 TBR(p=0.001)均高于未甲基化的患者。
HGG 中 [F]F-CHO 摄取动力学最好用 2 组织室模型来解释。传统的静态 [F]F-CHO-PET 指标已经通过从动力学模型中得出的灌注-转运常数(K)和净流入率(K)得到了验证。提示 [F]F-CHO 摄取率与 MGMT 甲基化之间存在关系,但需要进一步证实。